Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Caspase-1 inhibitor exerts brain-protective effects against sepsis-associated encephalopathy and cognitive impairments in a mouse model of sepsis.

Xu XE, Liu L, Wang YC, Wang CT, Zheng Q, Liu QX, Li ZF, Bai XJ, Liu XH.

Brain Behav Immun. 2019 May 27. pii: S0889-1591(19)30054-6. doi: 10.1016/j.bbi.2019.05.038. [Epub ahead of print]

PMID:
31145977
2.

Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.

Xie YH, Li LY, He JZ, Xu XE, Liao LD, Zhang Q, Xie JJ, Xu LY, Li EM.

Int J Biochem Cell Biol. 2019 Jul;112:79-87. doi: 10.1016/j.biocel.2019.05.005. Epub 2019 May 10.

PMID:
31082616
3.

Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.

Wang YC, Liu QX, Zheng Q, Liu T, Xu XE, Liu XH, Gao W, Bai XJ, Li ZF.

Inflammation. 2019 Mar 19. doi: 10.1007/s10753-019-00990-7. [Epub ahead of print]

PMID:
30887396
4.

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.

Jin X, Xu XE, Jiang YZ, Liu YR, Sun W, Guo YJ, Ren YX, Zuo WJ, Hu X, Huang SL, Shen HJ, Lan F, He YF, Hu GH, Di GH, He XH, Li DQ, Liu S, Yu KD, Shao ZM.

Sci Adv. 2019 Mar 6;5(3):eaat9820. doi: 10.1126/sciadv.aat9820. eCollection 2019 Mar.

5.

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.

Liu XY, Ma D, Xu XE, Jin X, Yu KD, Jiang YZ, Shao ZM.

Theranostics. 2018 Dec 8;8(22):6386-6399. doi: 10.7150/thno.29164. eCollection 2018.

6.

DSCAM-AS1 regulates the G1 /S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy.

Sun W, Li AQ, Zhou P, Jiang YZ, Jin X, Liu YR, Guo YJ, Yang WT, Shao ZM, Xu XE.

Cancer Med. 2018 Dec;7(12):6137-6146. doi: 10.1002/cam4.1603. Epub 2018 Nov 14.

7.

F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.

Xie L, Li LY, Zheng D, Xie YM, Xu XE, Tao LH, Liao LD, Xie YH, Cheng YW, Xu LY, Li EM.

Biomed Res Int. 2018 Sep 19;2018:2049313. doi: 10.1155/2018/2049313. eCollection 2018.

8.

Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.

Xu YW, Hong CQ, Wu ZY, Peng YH, Ran LQ, Yang SH, Huang BS, Liang XY, Chen HL, Wu JY, Xu XE, Deng JW, Zou HY, Fang WK, Li EM, Xu LY, Xie JJ.

Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):597-603. doi: 10.1016/j.clinre.2018.08.010. Epub 2018 Sep 13.

PMID:
30219694
9.

Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma.

Bai CY, Zhang JY, Shi TW, Bai YQ, Wu BL, Du ZP, Wu ZY, Xu XE, Wang SH, Wu JY, Te RY, Zhang JY, Xu LY, Li EM.

Oncol Lett. 2018 Jun;15(6):9353-9360. doi: 10.3892/ol.2018.8527. Epub 2018 Apr 18.

10.

Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma.

Guo JC, Wu Y, Chen Y, Pan F, Wu ZY, Zhang JS, Wu JY, Xu XE, Zhao JM, Li EM, Zhao Y, Xu LY.

Cancer Commun (Lond). 2018 Apr 9;38(1):4. doi: 10.1186/s40880-018-0277-0.

11.

MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma.

Liu W, He JZ, Wang SH, Liu DK, Bai XF, Xu XE, Wu JY, Jiang Y, Li CQ, Chen LQ, Li EM, Xu LY.

Br J Cancer. 2018 May;118(11):1476-1484. doi: 10.1038/s41416-018-0094-x. Epub 2018 May 16.

12.

Riboflavin Depletion Promotes Tumorigenesis in HEK293T and NIH3T3 Cells by Sustaining Cell Proliferation and Regulating Cell Cycle-Related Gene Transcription.

Long L, He JZ, Chen Y, Xu XE, Liao LD, Xie YM, Li EM, Xu LY.

J Nutr. 2018 Jun 1;148(6):834-843. doi: 10.1093/jn/nxy047.

PMID:
29741716
13.

Caspase-1-dependent pyroptosis of peripheral blood mononuclear cells predicts the development of sepsis in severe trauma patients: A prospective observational study.

Wang YC, Liu QX, Liu T, Xu XE, Gao W, Bai XJ, Li ZF.

Medicine (Baltimore). 2018 Feb;97(8):e9859. doi: 10.1097/MD.0000000000009859.

14.

SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.

Long L, Pang XX, Lei F, Zhang JS, Wang W, Liao LD, Xu XE, He JZ, Wu JY, Wu ZY, Wang LD, Lin DC, Li EM, Xu LY.

Cell Mol Life Sci. 2018 Jul;75(14):2643-2661. doi: 10.1007/s00018-018-2757-4. Epub 2018 Feb 10.

15.

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.

Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ, Li EM, Xu LY.

BMC Cancer. 2018 Feb 6;18(1):147. doi: 10.1186/s12885-018-4058-6.

16.

The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.

Zhang XD, Huang GW, Xie YH, He JZ, Guo JC, Xu XE, Liao LD, Xie YM, Song YM, Li EM, Xu LY.

Nucleic Acids Res. 2018 Feb 28;46(4):1793-1809. doi: 10.1093/nar/gkx1259.

17.

Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.

Ni PZ, He JZ, Wu ZY, Ji X, Chen LQ, Xu XE, Liao LD, Wu JY, Li EM, Xu LY.

Oncol Rep. 2017 Dec;38(6):3608-3618. doi: 10.3892/or.2017.6039. Epub 2017 Oct 17.

PMID:
29039594
18.

Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.

Lin DC, Dinh HQ, Xie JJ, Mayakonda A, Silva TC, Jiang YY, Ding LW, He JZ, Xu XE, Hao JJ, Wang MR, Li C, Xu LY, Li EM, Berman BP, Phillip Koeffler H.

Gut. 2018 Oct;67(10):1769-1779. doi: 10.1136/gutjnl-2017-314607. Epub 2017 Aug 31.

19.

A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.

He JZ, Wu ZY, Wang SH, Ji X, Yang CX, Xu XE, Liao LD, Wu JY, Li EM, Zhang K, Xu LY.

Hum Pathol. 2017 Aug;66:115-125. doi: 10.1016/j.humpath.2017.06.003. Epub 2017 Jun 9.

PMID:
28603065
20.

Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.

Li LY, Xie YH, Xie YM, Liao LD, Xu XE, Zhang Q, Zeng FM, Tao LH, Xie WM, Xie JJ, Xu LY, Li EM.

Int J Biochem Cell Biol. 2017 Jul;88:162-171. doi: 10.1016/j.biocel.2017.05.018. Epub 2017 May 11.

PMID:
28504189
21.

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer.

Zuo WJ, Jiang YZ, Wang YJ, Xu XE, Hu X, Liu GY, Wu J, Di GH, Yu KD, Shao ZM.

Clin Cancer Res. 2016 Oct 1;22(19):4859-4869.

22.

The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.

Zhang HF, Wu C, Alshareef A, Gupta N, Zhao Q, Xu XE, Jiao JW, Li EM, Xu LY, Lai R.

Stem Cells. 2016 Aug;34(8):2040-51. doi: 10.1002/stem.2395. Epub 2016 May 23.

23.

SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.

Zhu Y, Zhu MX, Zhang XD, Xu XE, Wu ZY, Liao LD, Li LY, Xie YM, Wu JY, Zou HY, Xie JJ, Li EM, Xu LY.

Hum Pathol. 2016 Jun;52:153-63. doi: 10.1016/j.humpath.2016.01.012. Epub 2016 Feb 5.

PMID:
26980013
24.

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.

Liu YR, Jiang YZ, Xu XE, Yu KD, Jin X, Hu X, Zuo WJ, Hao S, Wu J, Liu GY, Di GH, Li DQ, He XH, Hu WG, Shao ZM.

Breast Cancer Res. 2016 Mar 15;18(1):33. doi: 10.1186/s13058-016-0690-8.

25.

Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value.

Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu KD, Shao ZM.

Cancer Res. 2016 Apr 15;76(8):2105-14. doi: 10.1158/0008-5472.CAN-15-3284. Epub 2016 Mar 3.

26.

Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer.

Liu YR, Jiang YZ, Xu XE, Hu X, Yu KD, Shao ZM.

Clin Cancer Res. 2016 Apr 1;22(7):1653-62. doi: 10.1158/1078-0432.CCR-15-1555. Epub 2016 Jan 26.

27.

Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.

Xie JJ, Guo JC, Wu ZY, Xu XE, Wu JY, Chen B, Ran LQ, Liao LD, Li EM, Xu LY.

Hum Pathol. 2016 Feb;48:69-75. doi: 10.1016/j.humpath.2015.09.029. Epub 2015 Oct 22.

PMID:
26772401
28.

Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer.

Gao SP, Sun HF, Jiang HL, Li LD, Hu X, Xu XE, Jin W.

Oncotarget. 2015 Dec 22;6(41):43363-74. doi: 10.18632/oncotarget.6222.

29.

The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.

Zhang HF, Chen Y, Wu C, Wu ZY, Tweardy DJ, Alshareef A, Liao LD, Xue YJ, Wu JY, Chen B, Xu XE, Gopal K, Gupta N, Li EM, Xu LY, Lai R.

Clin Cancer Res. 2016 Feb 1;22(3):691-703. doi: 10.1158/1078-0432.CCR-15-1253. Epub 2015 Sep 24.

30.

Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer.

Gao SP, Sun HF, Jiang HL, Li LD, Hu X, Xu XE, Jin W.

Tumour Biol. 2016 Jan;37(1):1279-87. doi: 10.1007/s13277-015-3878-0. Epub 2015 Aug 20.

PMID:
26289846
31.

Data from a proteomic analysis of colonic fibroblasts secretomes.

Chen SX, Xu XE, Wang XQ, Cui SJ, Xu LL, Jiang YH, Zhang Y, Yan HB, Zhang Q, Qiao J, Yang PY, Liu F.

Data Brief. 2014 Aug 21;1:19-24. doi: 10.1016/j.dib.2014.08.003. eCollection 2014 Dec.

32.

Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.

Du ZP, Wu BL, Xie YM, Zhang YL, Liao LD, Zhou F, Xie JJ, Zeng FM, Xu XE, Fang WK, Li EM, Xu LY.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2240-50. doi: 10.1016/j.bbamcr.2015.07.007. Epub 2015 Jul 17.

33.

Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.

Bai YQ, Zhang JY, Bai CY, Xu XE, Wu JY, Chen B, Wu ZY, Wang SH, Shen J, Shen JH, Yao XD, Gao LZ, Wu B, Gu HL, Liu XH, Li X, Li EM, Xu LY.

Acta Histochem Cytochem. 2015 Jun 29;48(3):75-81. doi: 10.1267/ahc.14054. Epub 2015 Jun 25.

34.

Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice.

Yu SG, Zhang CJ, Xu XE, Sun JH, Zhang L, Yu PF.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3681-90. eCollection 2015.

35.

Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.

Li LY, Jiang H, Xie YM, Liao LD, Cao HH, Xu XE, Chen B, Zeng FM, Zhang YL, Du ZP, Chen H, Huang W, Jia W, Zheng W, Xie JJ, Li EM, Xu LY.

Oncotarget. 2015 Jun 30;6(18):15940-52.

36.

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.

Sun LL, Wu JY, Wu ZY, Shen JH, Xu XE, Chen B, Wang SH, Li EM, Xu LY.

Int J Cancer. 2015 Mar 15;136(6):E569-77. doi: 10.1002/ijc.29211. Epub 2014 Sep 24.

37.

A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.

Cao HH, Zheng CP, Wang SH, Wu JY, Shen JH, Xu XE, Fu JH, Wu ZY, Li EM, Xu LY.

PLoS One. 2014 Aug 25;9(8):e106007. doi: 10.1371/journal.pone.0106007. eCollection 2014.

38.

Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation.

Chen SX, Xu XE, Wang XQ, Cui SJ, Xu LL, Jiang YH, Zhang Y, Yan HB, Zhang Q, Qiao J, Yang PY, Liu F.

J Proteomics. 2014 Oct 14;110:155-71. doi: 10.1016/j.jprot.2014.07.031. Epub 2014 Aug 10.

PMID:
25118038
39.

The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.

Zhang JY, Bai CY, Bai YQ, Zhang JY, Wu ZY, Wang SH, Xu XE, Wu JY, Zhu Y, Rui Y, Li EM, Xu LY.

Hum Pathol. 2014 Oct;45(10):2014-22. doi: 10.1016/j.humpath.2014.05.014. Epub 2014 Jun 12.

PMID:
25090917
40.

Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Li LY, Li EM, Wu ZY, Cao HH, Shen JH, Xu XE, Chen B, Wu JY, Xu LY.

Int J Clin Exp Pathol. 2014 May 15;7(6):3132-40. eCollection 2014.

41.

Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging.

Yang X, Wang D, Ma Y, Zhao Q, Fallon JK, Liu D, Xu XE, Wang Y, He Z, Liu F.

Nanomedicine (Lond). 2014 Dec;9(18):2773-85. doi: 10.2217/nnm.14.50.

PMID:
25000945
42.

Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma.

Fang WK, Chen B, Xu XE, Liao LD, Wu ZY, Wu JY, Shen J, Xu LY, Li EM.

Acta Histochem. 2014 Jun;116(5):803-9. doi: 10.1016/j.acthis.2014.01.010. Epub 2014 Mar 12.

PMID:
24630396
43.

Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.

Zhang YF, Xu QX, Liao LD, Xu XE, Wu JY, Wu ZY, Shen JH, Li EM, Xu LY.

Dis Esophagus. 2015 Feb-Mar;28(2):196-203. doi: 10.1111/dote.12165. Epub 2014 Jan 15.

PMID:
24428760
44.

The prognostic implications of microvascular density and lymphatic vessel density in esophageal squamous cell carcinoma: Comparative analysis between the traditional whole sections and the tissue microarray.

Chen B, Fang WK, Wu ZY, Xu XE, Wu JY, Fu JH, Yao XD, Huang JH, Chen JX, Shen JH, Zheng CP, Wang SH, Li EM, Xu LY.

Acta Histochem. 2014 May;116(4):646-53. doi: 10.1016/j.acthis.2013.12.003. Epub 2014 Jan 9.

PMID:
24411070
45.

Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.

Sun LL, Holowatyj A, Xu XE, Wu JY, Wu ZY, Shen JH, Wang SH, Li EM, Yang ZQ, Xu LY.

Am J Cancer Res. 2013 Nov 1;3(5):509-17. eCollection 2013.

46.

miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.

Zhang HF, Zhang K, Liao LD, Li LY, Du ZP, Wu BL, Wu JY, Xu XE, Zeng FM, Chen B, Cao HH, Zhu MX, Dai LH, Long L, Wu ZY, Lai R, Xu LY, Li EM.

Carcinogenesis. 2014 Feb;35(2):292-301. doi: 10.1093/carcin/bgt320. Epub 2013 Sep 24.

PMID:
24064224
47.

Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma.

Fang WK, Liao LD, Li LY, Xie YM, Xu XE, Zhao WJ, Wu JY, Zhu MX, Wu ZY, Du ZP, Wu BL, Xie D, Guo MZ, Xu LY, Li EM.

J Pathol. 2013 Oct;231(2):257-70. doi: 10.1002/path.4236.

PMID:
23836524
48.

DACT2 is a candidate tumor suppressor and prognostic marker in esophageal squamous cell carcinoma.

Hou J, Liao LD, Xie YM, Zeng FM, Ji X, Chen B, Li LY, Zhu MX, Yang CX, Qing-Zhao, Chen T, Xu XE, Shen J, Guo MZ, Li EM, Xu LY.

Cancer Prev Res (Phila). 2013 Aug;6(8):791-800. doi: 10.1158/1940-6207.CAPR-12-0352. Epub 2013 Jun 26.

49.

Serum GFAP autoantibody as an ELISA-detectable glioma marker.

Wei P, Zhang W, Yang LS, Zhang HS, Xu XE, Jiang YH, Huang FP, Shi Q.

Tumour Biol. 2013 Aug;34(4):2283-92. doi: 10.1007/s13277-013-0770-7. Epub 2013 Apr 16.

PMID:
23589055
50.

κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.

Zhang YF, Xu QX, Liao LD, Xu XE, Wu JY, Shen J, Wu ZY, Shen JH, Li EM, Xu LY.

Hum Pathol. 2013 Sep;44(9):1756-65. doi: 10.1016/j.humpath.2012.11.025. Epub 2013 Apr 8.

PMID:
23574786

Supplemental Content

Support Center